Edition:
United States

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

527.40INR
29 Jul 2016
Change (% chg)

Rs6.75 (+1.30%)
Prev Close
Rs520.65
Open
Rs522.40
Day's High
Rs535.50
Day's Low
Rs520.00
Volume
1,785,352
Avg. Vol
1,871,060
52-wk High
Rs745.00
52-wk Low
Rs457.45

CIPL.NS

Chart for CIPL.NS

About

Cipla Limited is a pharmaceutical company. The Company's business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company offers APIs, formulations and veterinary products. As of March 31, 2015, the Company offered its services across five continents across the world. It offers... (more)

Overall

Beta: 0.44
Market Cap(Mil.): Rs423,824.19
Shares Outstanding(Mil.): 803.61
Dividend: 2.00
Yield (%): 0.38

Financials

  CIPL.NS Industry Sector
P/E (TTM): 28.22 38.77 39.28
EPS (TTM): 18.69 -- --
ROI: 12.87 15.17 14.40
ROE: 13.29 16.12 15.47

UPDATE 1-India's Cipla Q4 profit lags due to one-off charges in Europe, emerging markets

* Says exiting some emerging markets, modifying Europe business

May 24 2016

India drugmaker Cipla profit falls short of forecast, down 69 pct

MUMBAI, May 24 Cipla Ltd, India's fifth-largest drugmaker by sales, reported a fall of 69 percent in its quarterly earnings on Tuesday, far short of analysts' forecasts.

May 24 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.